Developer of a technology designed to extract highly sensitive nucleic acid quantification. The company’s technology uses power of digital PCR in cancer screening and monitoring, point-of-care diagnostics and viral load quantification applications, enabling researchers to get more accurate data, reduce labor cost and make confident decisions.

Acquired by Bio-Rad 2021